Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POM121 transmembrane nucleoporin-like 8, pseudogene (POM121L8P) is a human pseudogene mapped to chromosome 22. As a pseudogene, it is not thought to code for a functional protein, distinguishing it from canonical nucleoporins that are crucial structural elements of the nuclear pore complex. While pseudogenes can play roles in gene regulation—for example, by acting as decoys for microRNAs or generating regulatory noncoding RNAs—there is no evidence in major databases that POM121L8P has such characterized functions or disease involvement. POM121L8P is not considered a druggable therapeutic target, nor associated with approved drugs or biomarker status. It is most accurately described as a noncoding DNA element with high homology to functional nucleoporin genes but lacking known coding capacity or clinical relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POM121 transmembrane nucleoporin-like 8, pseudogene (POM121L8P).